Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation, Allogeneic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04269850
What this trial is testing

Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD

Who this might be right for
Intestinal GVHD
St. Petersburg State Pavlov Medical University 2
Not applicableNot Yet RecruitingNCT07762508
What this trial is testing

VABu Conditioning Regimen in Allo-HSCT for AML Patients

Who this might be right for
Leukemia, Myeloid, Acute(AML)Hematopoietic Stem Cell Transplantation (HSCT)
The First Affiliated Hospital of Soochow University 42
Early research (Phase 1)Ended earlyNCT00684255
What this trial is testing

Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)

Who this might be right for
Systemic Lupus ErythematosusSystemic Sclerosis
New York Medical College 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT02861417
What this trial is testing

Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmHigh Risk Acute Myeloid LeukemiaHigh Risk Myelodysplastic Syndrome+11 more
M.D. Anderson Cancer Center 204
Testing effectiveness (Phase 2)Study completedNCT03149055
What this trial is testing

Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)

Who this might be right for
Hematologic MalignancyMyeloproliferative Disorder
Memorial Sloan Kettering Cancer Center 99
Testing effectiveness (Phase 2)Study completedNCT03820908
What this trial is testing

Bisantrene for Relapsed /Refractory AML

Who this might be right for
Acute Myelogenous LeukemiaAllogeneic Stem Cell Transplantation
Sheba Medical Center 10
Early research (Phase 1)WithdrawnNCT04655391
What this trial is testing

Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Have Undergone Hematopoietic Cell Transplantation

Who this might be right for
Recurrent Acute Myeloid Leukemia
City of Hope Medical Center
Not applicableLooking for participantsNCT06715046
What this trial is testing

Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
GVHD - Graft-Versus-Host DiseaseInfections After HSCTTransplant Associated Microangiopathy TAM+2 more
University of Turin, Italy 30
Testing effectiveness (Phase 2)WithdrawnNCT05726682
What this trial is testing

Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Allogenic Stem Cell Transplantation
Sanofi
Testing effectiveness (Phase 2)Study completedNCT01162096
What this trial is testing

Reduced Intensity Haploidentical Transplant for Hematological Malignancies

Who this might be right for
Hematological Malignancies
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 34
Not applicableLooking for participantsNCT06569082
What this trial is testing

CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure

Who this might be right for
Graft FailurePoor Graft Function
NYU Langone Health 21
Testing effectiveness (Phase 2)Study completedNCT00202917
What this trial is testing

Haploidentical Transplantation With CD3/CD19 Depleted Grafts in Patients With Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
University Hospital Tuebingen 61
Testing effectiveness (Phase 2)Study completedNCT01664910
What this trial is testing

CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies

Who this might be right for
Hematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT00385788
What this trial is testing

Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease

Who this might be right for
Hodgkin's Disease
M.D. Anderson Cancer Center 52
Large-scale testing (Phase 3)Ended earlyNCT04390113
What this trial is testing

Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)

Who this might be right for
BK Virus InfectionHemorrhagic Cystitis
AlloVir 97
Testing effectiveness (Phase 2)Active Not RecruitingNCT03674047
What this trial is testing

Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT)

Who this might be right for
Other Cancer
Massachusetts General Hospital 50
Not applicableUnknownNCT02923076
What this trial is testing

HIV Eradication Through Cord-blood Transplantation

Who this might be right for
HIV
Puerta de Hierro University Hospital 5
Testing effectiveness (Phase 2)Study completedNCT00003116
What this trial is testing

High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Case Comprehensive Cancer Center 66
Testing effectiveness (Phase 2)Looking for participantsNCT05827835
What this trial is testing

CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases

Who this might be right for
Hematologic DiseasesNeoplasms
Zhejiang University 30
Testing effectiveness (Phase 2)Study completedNCT03389035
What this trial is testing

Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Pediatric and Adult Patients With r/r ALL Post HSCT

Who this might be right for
Acute Lymphoblastic Leukemia, in Relapse
Fondazione Matilde Tettamanti Menotti De Marchi Onlus 21
Next Page